Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2006-07-11

Original market date: See footnote 1

1996-12-31

Product name:

PHENERGAN EXPECTORANT WITH CODEINE LIQUID

DIN:

02162180 Electronic product monograph is not available

Company:

COLUMBIA LABORATORIES CANADA INC
36 1111 Flint Road
North York
Ontario
Canada M3J 3C7

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Narcotic (CDSA I)

 

American Hospital Formulary Service (AHFS): See footnote 3

48:08.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS

Active ingredient group (AIG) number:See footnote5

0311735001

List of active ingredient(s)
Active ingredient(s) Strength
CODEINE PHOSPHATE 10 MG / 5 ML
POTASSIUM GUAIACOL SULPHONATE 40 MG / 5 ML
PROMETHAZINE HYDROCHLORIDE 5.65 MG / 5 ML
Version 4.0.2
Date modified: